Yasemin Şanlı
-
- Radiopharmaceutical Chemistry and Applications 18
- Medical Imaging Techniques and Applications 7
- Oncology top 5%
- Peptidase Inhibition and Analysis 14
- Cancer Research top 10%
- Protease and Inhibitor Mechanisms 8
- Neurology top 10%
- Neuroblastoma Research and Treatments 6
-
- Prostate Cancer Treatment and Research 16
- Prostate Cancer Diagnosis and Treatment 8
-
- Neuroendocrine Tumor Research Advances 10
- Co-authors
- Serkan KuyumcuCüneyt TürkmenDuygu Has ŞimşekZeynep Gözde Özkanİşık AdaletSeher ÜnalAyşe MudunEmine Göknur Işık
- Journals
- Annals of Nuclear Medicine (15 papers)European Journal of Nuclear Medicine and Molecular Imaging (9 papers)Cancer Biotherapy and Radiopharmaceuticals (5 papers)
- Partner nations
- TürkiyeUnited StatesNew Zealand
In The Last Decade
Yasemin Şanlı
82 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 83
- Radiology, Nuclear Medicine and Imaging 472
- Oncology 531
- Cancer Research 257
- Neurology 186
- Pulmonary and Respiratory Medicine 328
Countries citing papers authored by Yasemin Şanlı
This map shows the geographic impact of Yasemin Şanlı's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasemin Şanlı with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasemin Şanlı more than expected).
Fields of papers citing papers by Yasemin Şanlı
This network shows the impact of papers produced by Yasemin Şanlı. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasemin Şanlı. The network helps show where Yasemin Şanlı may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yasemin Şanlı, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 9 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 2 | |
| 9 | 2023 | 15 | |
| 10 | 2021 | 1 | |
| 11 | 2021 | 5 | |
| 12 | 2021 | 1 | |
| 13 | 2021 | 5 | |
| 14 | 2021 | 2 | |
| 15 | 2020 | 3 | |
| 16 | 2020 | 1 | |
| 17 | 2018 | 8 | |
| 18 | 2015 | 64 | |
| 19 | 2012 | 3 | |
| 20 | 2007 | 122 |
About Yasemin Şanlı
Yasemin Şanlı is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 86 papers that have together received 1.4k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (18 papers), Prostate Cancer Treatment and Research (16 papers), Peptidase Inhibition and Analysis (14 papers), Neuroendocrine Tumor Research Advances (10 papers), Protease and Inhibitor Mechanisms (8 papers), Prostate Cancer Diagnosis and Treatment (8 papers), Medical Imaging Techniques and Applications (7 papers) and Neuroblastoma Research and Treatments (6 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (472 citations), Oncology (531 citations) and Cancer Research (257 citations). Yasemin Şanlı has collaborated with scholars based in Türkiye, United States and New Zealand. Frequent co-authors include Serkan Kuyumcu, Cüneyt Türkmen, Duygu Has Şimşek, Zeynep Gözde Özkan, İşık Adalet, Seher Ünal, Ayşe Mudun, Emine Göknur Işık, Rathan M. Subramaniam and Ishan Garg. Their work appears in journals such as Annals of Nuclear Medicine, European Journal of Nuclear Medicine and Molecular Imaging, Cancer Biotherapy and Radiopharmaceuticals, Nuclear Medicine Communications and American Journal of Roentgenology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.